CI Investments Inc
KRTX

CI Investments Inc’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

CI Investments Inc’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-548
Closed -$173K – 1322
2023
Q4 		$173K Sell
548
-94
-15% -$18.3K ﹤0.01% 705
2023
Q3 		$109K Sell
642
-7
-1% -$1.32K ﹤0.01% 813
2023
Q2 		$141K Buy
649
+405
+166% +$86.8K ﹤0.01% 705
2023
Q1 		$44K Buy
244
+203
+495% +$38.8K ﹤0.01% 936
2022
Q4 		$8K Buy
+41
New +$8.79K ﹤0.01% 1148

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

CI Investments Inc's KRTX Position: Q1 2024 in Review

CI Investments Inc sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 548 shares — an estimated $173K sold.

CI Investments Inc first reported a position in KRTX in Q4 2022 and held it in 5 quarters. The position peaked at $173K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • CI Investments Inc reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • CI Investments Inc sold 548 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $173K.
  • CI Investments Inc first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • CI Investments Inc's Karuna Therapeutics, Inc. Common Stock position peaked at $173K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on CI Investments Inc's 13F filing for Q1 2024, filed 13 May 2024.